Virtus LifeSci Biotech Products ETF (BBP)

Assets	$19.19M
Expense Ratio	0.79%
PE Ratio	n/a
Shares Out	350,004
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Ratio	n/a
1-Year Return	+3.26%

Volume	n/a
Open	n/a
Previous Close	53.52
Day's Range	n/a
52-Week Low	48.65
52-Week High	69.12
Beta	0.65
Holdings	64
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

22.83% of assets

Name	Symbol	Weight
Sage Therapeutics, Inc.	SAGE	2.49%
BeiGene, Ltd.	ONC	2.47%
Halozyme Therapeutics, Inc.	HALO	2.39%
TG Therapeutics, Inc.	TGTX	2.38%
BridgeBio Pharma, Inc.	BBIO	2.31%
ADMA Biologics, Inc.	ADMA	2.22%
Ascendis Pharma A/S	ASND	2.20%
Gilead Sciences, Inc.	GILD	2.16%
Zai Lab Limited	ZLAB	2.13%
Rhythm Pharmaceuticals, Inc.	RYTM	2.08%